Table 3.
Performance of the GAD-2 in detecting anxiety disorder among patients in routine care* (N=1 196)
Cut-point | Sensitivity (%) | Specificity (%) | Correctly classified (%) | LR+ | LR− |
---|---|---|---|---|---|
≥0 | 100 | 0 | 1.42 | 1.00 | 0,00 |
≥1 | 88.24 | 35.03 | 35.79 | 1.36 | 0.34 |
≥2 | 82.35 | 56.74 | 57.11 | 1.90 | 0.31 |
≥3 | 58.82 | 75.66 | 75.42 | 2.42 | 0.54 |
≥4 | 11.76 | 87.11 | 86.04 | 0.91 | 1.01 |
≥5 | 0 | 94.49 | 93.14 | 0.00 | 1.06 |
≥6 | 0 | 96.10 | 94.73 | 0.00 | 1.04 |
>6 | 0 | 100 | 98.58 | 1.00 | 1.00 |
GAD-2 = Generalized Anxiety Disorder measure; LR+ = likelihood ratio positive; LR− = likelihood ratio negative.
Adult Primary Care assessment by the primary healthcare nurse was used as a diagnostic reference standard.